I know there's a lot of excitement about $VKTX, but I have noticed the decline in the RSI with each recent new high (negative divergence) and the MACD has been turning down....I especially pay attention to both positive and negative divergences.
On the bullish side we have a strong price trend with impressive On Balance Volume and Accum/Distribution signals...
Good luck on your binary event...seems many are in the bullish camp
If VKTX hope you are right WRT to VK2809 top line results this week in NASH. While you are correct that it is 4-5 weeks after last follow-up, this is a very small company (21 people as of 12/31/22) and I suspect they have been very busy with starting the phase 2 trial on VK2735 plus they just started the ORAL trial on VK2735.
I think June is more likely for results. For maximum impact, they could time the release to be around EASL June 21-24.
I'm holding through this event as well because: - risk is reduced by VK2735 phase 1 results and they have 400+ mill in cash. - large short position will amplify good results which I think are likely.
VKTX- Viking Therapeutics Announces Positive Top-Line Results from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH)
News 
Market Data 
Discover 
